Duloxetine Boehringer Ingelheim

RSS

duloxetine

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Duloxetine Boehringer Ingelheim has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 17/01/2013

Authorisation details

Product details
Name
Duloxetine Boehringer Ingelheim
Agency product number
EMEA/H/C/001007
Active substance
duloxetine
International non-proprietary name (INN) or common name
duloxetine
Therapeutic area (MeSH)
Diabetic Neuropathies
Anatomical therapeutic chemical (ATC) code
N06AX21
Publication details
Marketing-authorisation holder
Boehringer Ingelheim International GmbH
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
08/10/2008
Contact address
Binger Str 173
D-55216 Ingelheim am Rhein
Germany

Product information

07/12/2009 Duloxetine Boehringer Ingelheim - EMEA/H/C/001007 - P46/008

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Psychoanaleptics

Therapeutic indication

Treatment of diabetic peripheral neuropathic pain in adults.

Assessment history

How useful was this page?

Add your rating